Effect Of Nagaradi Granules In Balatisara (Diarrhea in children)
Phase 1
- Conditions
- Health Condition 1: K928- Other specified diseases of the digestive system
- Registration Number
- CTRI/2023/07/055275
- Lead Sponsor
- Rishikul Campus
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Mild to moderate case of balatisara
Exclusion Criteria
Children below age of 5 years and above 16 years.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Relief in subjective parameters like - <br/ ><br>Muhur muhur pravriti (Frequency of stool), udarshoola (abdominal pain) and atidrava mala pravriti (consistency) <br/ ><br>Timepoint: The assesment will be done in the time period of 7 days on daily basis with the administration of drug and after 7 days without medication.
- Secondary Outcome Measures
Name Time Method Relief in objective parameters like- <br/ ><br>Consistency & foul smellTimepoint: The assessment will be done in the time period of 07 days.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the active compounds and molecular pathways targeted by Nagaradi Granules in pediatric diarrhea (Balatisara)?
How does Nagaradi Granules compare to standard oral rehydration solutions and zinc in treating Balatisara (pediatric diarrhea)?
What biomarkers predict response to Nagaradi Granules in CTRI/2023/07/055275 for pediatric diarrhea (Balatisara)?
What are the potential adverse events and safety management strategies for Nagaradi Granules in Phase I pediatric trials?
Are there other herbal formulations or combination therapies being studied for K928-related pediatric digestive disorders?